Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Vicus

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Current Oncology (Toronto, Ont.)|February 24, 2023
Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group StudyChrista Aubrey, Gregory R Pond, Limor Helpman, et al.
Cancer|May 13, 2021
Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancerSoyoun Rachel Kim, Alicia Tone, Raymond H Kim, et al.
Cancer|August 19, 2020
Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancerSoyoun Rachel Kim, Alicia Tone, Raymond H Kim, et al.
Gynecologic Oncology|March 8, 2025
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)Allan Covens, Helen Q Huang, Bradley J Monk, et al.
Gynecologic Oncology|February 8, 2023
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancerAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2023
Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085]Amy Jamieson, Jutta Huvila, Derek Chiu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific DeathAmy Jamieson, Jutta Huvila, Derek Chiu, et al.
Gynecologic Oncology|March 5, 2022
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classificationAmy Jamieson, Jutta Huvila, Emily F Thompson, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian CancerKim Ma, Basile Tessier-Cloutier, Alon D Altman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 14, 2022
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classificationEmily F Thompson, Jutta Huvila, Amy Jamieson, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Current Oncology (Toronto, Ont.)|February 24, 2023
Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group StudyChrista Aubrey, Gregory R Pond, Limor Helpman, et al.
Cancer|May 13, 2021
Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancerSoyoun Rachel Kim, Alicia Tone, Raymond H Kim, et al.
Cancer|August 19, 2020
Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancerSoyoun Rachel Kim, Alicia Tone, Raymond H Kim, et al.
Gynecologic Oncology|March 8, 2025
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)Allan Covens, Helen Q Huang, Bradley J Monk, et al.
Gynecologic Oncology|February 8, 2023
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancerAmy Jamieson, Jutta Huvila, Samuel Leung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2023
Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085]Amy Jamieson, Jutta Huvila, Derek Chiu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific DeathAmy Jamieson, Jutta Huvila, Derek Chiu, et al.
Gynecologic Oncology|March 5, 2022
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classificationAmy Jamieson, Jutta Huvila, Emily F Thompson, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian CancerKim Ma, Basile Tessier-Cloutier, Alon D Altman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 14, 2022
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classificationEmily F Thompson, Jutta Huvila, Amy Jamieson, et al.
Pageof 9